PRO

Call2Recycle and Greentec expand their partnership to support the growth of battery recycling in Ontario

Retrieved on: 
Thursday, February 29, 2024

This strategic partnership will optimize the battery recycling efforts in the province and enhance Canada’s overall recycling infrastructure.

Key Points: 
  • This strategic partnership will optimize the battery recycling efforts in the province and enhance Canada’s overall recycling infrastructure.
  • Under the expanded agreement, Greentec’s facility in Cambridge (Ontario) will provide battery sorting services to Call2Recycle starting May 2024.
  • This initiative will further support Call2Recycle’s battery collection and recycling efforts in Ontario, where it serves as the largest registered battery Producer Responsibility Organization (PRO).
  • "This expansion of our partnership with Greentec marks another significant milestone in Call2Recycle’s commitment to further battery recycling capacities in Canada," said Joe Zenobio, President of Call2Recycle Canada.

Floor & Decor Announces Grand Opening of Summerfield, Florida Store

Retrieved on: 
Wednesday, February 21, 2024

In appreciation of its valued builders, contractors, architects, designers, remodelers, flooring installers and realtors, Floor & Decor welcomes its PRO network to the new location with a special PRO VIP Grand Opening event on March 5.

Key Points: 
  • In appreciation of its valued builders, contractors, architects, designers, remodelers, flooring installers and realtors, Floor & Decor welcomes its PRO network to the new location with a special PRO VIP Grand Opening event on March 5.
  • In addition, the Summerfield Floor & Decor store will give away a $5,000 Floor Makeover as part of its grand opening festivities.
  • Following the grand opening, the Summerfield Floor & Decor store will host a family friendly “Best In Town” event on February 24, beginning at 10:00 am ET.
  • Floor & Decor will partner with other local businesses to promote their new store opening.

‘This is a Foul’: Refs’ Union Condemns Lockout as PRO Bars Major League Soccer Refs from Working Matches

Retrieved on: 
Sunday, February 18, 2024

The Professional Soccer Referees Association (PSRA), the certified labor union representing officials working Major League Soccer (MLS) matches, condemns the lockout imposed by MLS and its referee employment organization, the Professional Referee Organization (PRO).

Key Points: 
  • The Professional Soccer Referees Association (PSRA), the certified labor union representing officials working Major League Soccer (MLS) matches, condemns the lockout imposed by MLS and its referee employment organization, the Professional Referee Organization (PRO).
  • This leaves players, teams and fans without the top professional officials in the league as the 2024 MLS season kicks off.
  • PSRA has indicated its intention to continue bargaining in good faith, while MLS and PRO’s response was a lockout, denying employment to the top officials in the league.
  • PSRA comprises approximately 260 members, who are employed by PRO, the organization responsible for servicing MLS and other professional soccer leagues in the United States.

EMA and European Organisation for Research and Treatment of Cancer (EORTC) workshop: How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?, Online, European Medicines Agency, Amsterdam, t[...]

Retrieved on: 
Sunday, March 10, 2024

This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.

Key Points: 
  • This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.
  • The aims of the workshop are to:
    - Understand the current global landscape on the use of PROs and HRQOL for evaluation of anti-cancer treatments across different stakeholder groups.
  • - Understand the use of validated PRO questionnaires to measure core HRQOL outcomes and disease-related symptoms; and PRO Item Libraries in the development of trial-specific/treatment-specific item lists.
  • The recording of this meeting will be made available after the event.

EMARKETER Brand Returns With the Addition of a Powerful New Suite of Forecasting and Insights Tools

Retrieved on: 
Monday, March 4, 2024

NEW YORK, March 4, 2024 /PRNewswire/ -- EMARKETER, the go-to forecasts, data, and insights provider, today launched PRO+, a comprehensive suite of new product features and data sets. With over 25 years of experience, EMARKETER has developed a unique ability to produce credible forecasts and benchmarks that empower strategic decisions for revenue-driving teams. PRO+ builds on this legacy, empowering clients to make informed decisions faster through:

Key Points: 
  • With over 25 years of experience, EMARKETER has developed a unique ability to produce credible forecasts and benchmarks that empower strategic decisions for revenue-driving teams.
  • New and expanded data sets: Rigorously vetted and transparent data tied into consumer behavior that is reliable and trustworthy.
  • "Returning to EMARKETER, the brand trusted for over twenty-five years, reflects our strategic focus on digital marketing, advertising and commerce," said EMARKETER CEO Matthias Braun.
  • EMARKETER is the go-to forecasts, data, and insights provider for marketing, advertising, and commerce professionals.

Avidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ Trial

Retrieved on: 
Monday, March 4, 2024

SAN DIEGO, March 4, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced new positive long-term AOC 1001 data from the MARINA open-label extension (MARINA-OLE™) trial showing reversal of disease progression in people living with myotonic dystrophy type 1 (DM1) across multiple endpoints including vHOT, muscle strength and activities of daily living when compared to END-DM1 natural history data. These endpoints are the same key endpoints that will be used in the global Phase 3 HARBOR™ trial for people living with DM1. The primary endpoint in the Phase 3 HARBOR trial is video hand opening time (vHOT), and key secondary endpoints include muscle strength as measured by hand grip strength and quantitative muscle testing (QMT) total score, and activities of daily living as measured by DM1-Activ. Avidity is accelerating the global Phase 3 HARBOR trial initiation to the second quarter of 2024.

Key Points: 
  • These endpoints are the same key endpoints that will be used in the global Phase 3 HARBOR™ trial for people living with DM1.
  • Avidity is accelerating the global Phase 3 HARBOR trial initiation to the second quarter of 2024.
  • Avidity also announced delpacibart etedesiran as the approved international nonproprietary name of AOC 1001, abbreviated as del-desiran.
  • ET to discuss new positive long-term del-desiran (AOC 1001) data from the MARINA-OLE™ trial in people living with DM1.

HealthTree Foundation Announces Launch of HealthTree Research Hub in Multiple Myeloma

Retrieved on: 
Friday, March 1, 2024

SALT LAKE CITY, Utah, March 1, 2024 /PRNewswire/ -- HealthTree Foundation, a global non-profit organization using cutting-edge technology that unites patients and researchers to accelerate cures, is excited to announce the release of its highly anticipated HealthTree Research Hub portal.

Key Points: 
  • HealthTree Research Hub is an online research portal that facilitates real-world data (RWD) research.
  • HealthTree Research Hub provides researchers access to over 14,000 myeloma patients who contribute anonymized data to the HealthTree Cure Hub patient portal.
  • HealthTree Research Hub will facilitate over 100 research projects in the next 20 months for myeloma researchers.
  • HealthTree Research Hub will additionally be open for beta research projects in lymphoma, leukemia and MPNs in 2024.

Charbroil Revolutionizes Outdoor Cooking with New Commercial Series™ and PRO Series™ Grill & Griddle Combos

Retrieved on: 
Thursday, February 29, 2024

The Charbroil® Commercial Series™ Grill & Griddle Combo unlocks endless flavor possibilities that are sure to satisfy the entire crew.

Key Points: 
  • The Charbroil® Commercial Series™ Grill & Griddle Combo unlocks endless flavor possibilities that are sure to satisfy the entire crew.
  • Featuring a cutting-edge modular cooking system, the Charbroil® Commercial Series™ Grill & Griddle Combo seamlessly transitions from classic gas grilling to griddle cooking in 90 seconds or less.
  • Additional features of the Charbroil® Commercial Series™ Grill & Griddle Combo include:
    Versatility to effortlessly transform into a gas grill, griddle or charcoal grill.
  • In addition to the Commercial Series™ Grill & Griddle Combo, Charbroil® also offers the PRO Series™ Grill & Griddle Combo, which features the same modular cooking system and is available at select retailers and at www.charbroil.com .

Music Licensing, Inc. Highlights Milestones and Market Impact in 2023 Year-End Audit

Retrieved on: 
Friday, February 16, 2024

NAPLES, Fla., Feb. 16, 2024 /PRNewswire/ -- Music Licensing, Inc. (OTC: SONG), operating under the brand Pro Music Rights, proudly announces significant achievements and market impact as revealed in its 2023 year-end audit, scheduled for completion today.

Key Points: 
  • NAPLES, Fla., Feb. 16, 2024 /PRNewswire/ -- Music Licensing, Inc. (OTC: SONG), operating under the brand Pro Music Rights, proudly announces significant achievements and market impact as revealed in its 2023 year-end audit, scheduled for completion today.
  • Our extensive licensee network includes prominent entities such as TikTok, iHeart Media, Triller, Napster, 7Digital, Vevo, and many others, reflecting the trust and recognition garnered by Pro Music Rights.
  • With an estimated market share of 7.4% in the United States, Music Licensing, Inc. represents over 2,500,000 works, showcasing a diverse catalog featuring renowned artists from various genres.
  • The completion of the 2023 year-end audit marks a pivotal moment for Music Licensing, Inc., as it aims to showcase its financial performance and strategic positioning in the market.

Music Licensing, Inc. (OTC: SONG) Highlights Milestones and Market Impact in 2023 Year-End Audit

Retrieved on: 
Friday, February 16, 2024

Naples Florida, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG), operating under the brand Pro Music Rights, proudly announces significant achievements and market impact as revealed in its 2023 year-end audit, scheduled for completion today.

Key Points: 
  • Naples Florida, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG), operating under the brand Pro Music Rights, proudly announces significant achievements and market impact as revealed in its 2023 year-end audit, scheduled for completion today.
  • Our extensive licensee network includes prominent entities such as TikTok, iHeart Media, Triller, Napster, 7Digital, Vevo, and many others, reflecting the trust and recognition garnered by Pro Music Rights.
  • With an estimated market share of 7.4% in the United States, Music Licensing, Inc. represents over 2,500,000 works, showcasing a diverse catalog featuring renowned artists from various genres.
  • The completion of the 2023 year-end audit marks a pivotal moment for Music Licensing, Inc., as it aims to showcase its financial performance and strategic positioning in the market.